Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6592.0000 99.00 (1.52%)
NSE Jun 20, 2025 15:31 PM
Volume: 560.9K
 

6592.00
1.52%
Axis Direct
While Q3 EBITDA was inline with estimate, PAT of Rs 2.68bn was 10% below our estimate due to higher taxes. Revenue growth was muted at 13% YoY (9M was 14% YoY, 10% in cc terms). Divi'sguided for 10- 15% cc revenue growth for FY17/18 vs.15% earlier, given delay in adding capacities (Vizagand Kakina..
Divi's Laboratories Ltd.'s price crossed above 30Day SMA today
More from Divi's Laboratories Ltd.
Recommended